Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07748793Recruiting
Fat grafting for treating chronic tendon pain
This trial injects your own fat into the painful tendon area to help it heal. It is for people with long-lasting tendon pain that has not improved with other treatments like physical therapy or injections.
New York, New YorkAges 18–80 - NCT03131726RecruitingPhase 3
Simvastatin for Graves eye disease in mild-to-moderate cases
This trial tests whether simvastatin (a cholesterol medicine) can improve eye symptoms from Graves’ eye disease. It is aimed at people with active mild-to-moderate disease and will also check safety with blood tests, heart/skin tolerance, and stomach health.
MalmöAges 18–70 - NCT06025149Recruiting
Study of a New Biological Heart Valve 'UniLine'
This study tests a new biological heart valve called 'UniLine' for people who need to replace their mitral valve (the valve between the left heart chambers) or aortic valve (the main valve sending blood to the body) for the first time. If you qualify, you would have planned surgery (not an emergency) and need to be free of certain other serious health conditions.
Kemerovo, Kemerovo OblastAges 18–80 - NCT06118710RecruitingPhase 4
Can we skip dexamethasone before paclitaxel?
This study tests whether it is safe to skip the steroid (dexamethasone) that is normally given before paclitaxel chemotherapy. If you are about to start paclitaxel for a solid tumor, this trial may help reduce side effects from premedication.
Rotterdam, South HollandAges 18 years+ - NCT06613113Recruiting
Fruquintinib, adebrelimab, and radiation for advanced colorectal cancer
This trial tests a combination of two drugs (fruquintinib and adebrelimab) plus low or high dose radiation for people with advanced colorectal cancer that has not responded to standard treatments. The goal is to see if this combination can shrink tumors or slow the disease.
Ningbo, ZhejiangAges 18 years+ - NCT06611020Recruiting
Vaccine after cone surgery for cervical dysplasia
This trial tests whether giving an HPV vaccine after a cone biopsy (a surgery to remove abnormal cells from the cervix) helps prevent the HPV-related disease from coming back. It may be an option for patients who have had treatment for cervical dysplasia and have not been vaccinated against HPV before.
Milan, LombardyAges 18 years+ - NCT06185972RecruitingPhase 2
MRI-guided ultrasound radiation for breast and chest cancer
This trial tests a new way to give radiation therapy using MRI imaging and ultrasound to make the radiation more targeted and potentially safer. If you have chest-wall or breast cancer and are already scheduled for radiation, this approach might offer a more precise treatment option.
Toronto, OntarioAges 18 years+ - NCT02979951Recruiting
IV fosfomycin for serious bacterial infections
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
Hall in TirolAges 18 years+ - NCT06619301RecruitingPhase 3
Insulin options for diabetes in pregnancy
This trial compares two types of insulin (glargine and NPH) to see which works better for managing blood sugar in pregnant women with gestational diabetes or type 2 diabetes. If you need to start insulin during pregnancy, you may be able to join.
Maywood, IllinoisAges 18 years+ - NCT05769868RecruitingPhase 3
Esmolol test to spot heart problems in diabetes, cirrhosis, and cancer
This trial tests whether esmolol (a short-acting heart medicine) can help doctors identify certain heart-related problems in people with type 2 diabetes, liver scarring (cirrhosis), or specific cancers. It’s mainly about improving how heart issues are detected during ultrasound testing.
Barcelona, BarcelonaAges 18 years+ - NCT04265599Recruiting
Study of high calcium after oil injections
This study looks at why some people develop high blood calcium after receiving an oil injection into a muscle. It may help researchers understand the cause and find better ways to treat it.
CopenhagenAges 18 years+ - NCT06341543Recruiting
CMV blood test to guide treatment after organ transplant
This study uses a blood test (QuantiFERON-CMV) to help decide whether people with a silent (no symptoms) CMV infection after a solid organ transplant need treatment. If you have a low-to-moderate level of CMV in your blood without fever or organ issues, this trial may help your doctor choose the safest approach.
Grenoble, MarylandAges 18 years+ - NCT06499233RecruitingPhase 4
Study on preventing pneumocystis pneumonia in autoimmune disease
This trial tests whether a preventive treatment can stop pneumocystis pneumonia (a lung infection) in people with autoimmune inflammatory rheumatic diseases who are taking steroids or other immune-suppressing medicines. It aims to find the safest and most effective way to protect you from this serious infection.
Wuhan, HubeiAges 18 years+ - NCT06621368Recruiting
Resistance training for healthy aging in older women
This study tests if two years of resistance exercise helps older women stay healthy and active. It's for postmenopausal women aged 60+ who are not currently exercising regularly.
Londrina, ParanáAges 60 years+ - NCT06591884RecruitingPhase 1/Phase 2
Spray vs ointment for oral lichen planus
This trial tests a new spray version of the medication tacrolimus (enclosed in tiny particles) compared to a standard ointment for treating painful mouth sores caused by oral lichen planus. It aims to see if the spray works better and is easier to use.
Porto Alegre, Rio Grande do SulAges 18 years+ - NCT07734103RecruitingPhase 2
Lumateperone for Adult Stuttering
This study tests whether the drug lumateperone can help adults with stuttering, a speech disorder that began in childhood. If you have moderate or severe stuttering, this treatment might reduce symptoms.
Costa Mesa, CaliforniaAges 18–65 - NCT07734038RecruitingPhase 2
Venetoclax and Zanubrutinib for CLL and SLL
This study tests a combination of two oral medications, venetoclax and zanubrutinib, for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It aims to see if this combination is safe and effective, either as a first treatment or after a previous treatment.
Columbus, OhioAges 18 years+ - NCT07739784Recruiting
Personality and side effects of glaucoma eye drops
This study looks at whether your personality affects how you experience side effects from glaucoma eye drops. The results may help doctors choose the best treatment for you and provide more personalized care.
Montreal, QuebecAges 18 years+ - NCT07736144Recruiting
Herbal formula study for fibromyalgia pain relief
This study tests a Chinese herbal formula called Yangyin Roujin (which nourishes yin and softens the muscles) to see if it helps reduce pain and other symptoms of fibromyalgia. If you have fibromyalgia and a pain level of 4 or more, you may be able to join.
Beijing, Beijing MunicipalityAges 18–75 - NCT07740447Recruiting
Non-surgical gum treatment and its effect on body chemistry
This study looks at whether a standard non-surgical gum disease treatment changes certain chemicals in your blood or saliva. It may help show how treating gum disease can improve your overall health.
Catania, ItalyAges 18–70 - NCT07734870RecruitingPhase 2
Tirzepatide for treating scarring hair loss (CCCA)
This study tests whether tirzepatide (Mounjaro) can help treat a specific type of scarring hair loss called CCCA. It is for people whose hair loss is still active and who are not taking diabetes or weight-loss medications.
Baltimore, MarylandAges 18–80 - NCT07732660Recruiting
Building skills and reducing stigma for young people with HIV in Zambia
This trial helps young people aged 18 to 24 living with HIV in three districts of Zambia. It aims to reduce stigma and build job skills to improve their lives.
Lusaka, Lusaka ProvinceAges 18–24 - NCT07738081Enrolling by invitation
Testing a new therapy for substance use and emotional health
This trial is testing a new type of therapy (the Unified Protocol) that helps people who are in treatment for substance use and also have depression or anxiety. The goal is to see if this approach can improve emotional well-being and reduce substance use.
OviedoAges 18 years+ - NCT07735585Recruiting
App-based support for alcohol use disorder
This study tests a smartphone app that uses rewards to help people reduce or stop drinking. You may be eligible if you have alcohol use disorder and are seeking treatment at a specific clinic in São Paulo.
São Paulo, São PauloAges 18–70
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.